🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare the incremental area under the curve from...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-05-20
Trial ID
NCT02428699
Treatments Being Tested
This study aims to investigate the pathophysiology of recurrent pericarditi...
Status
Unknown
Location
Saarland University
Start Date
2023-07-01
Trial ID
NCT05925790
Treatments Being Tested
EBO-PEP is a multicentre, multi-epidemic, phase III, comparative, controlle...
Status
Not Yet Recruiting
Location
National Institute for Biomedical Research (INRB)
Start Date
2026-09
Trial ID
NCT06841614
To investigate the effect of marine peptide combined with dietary protein o...
Status
Unknown
Location
Haukeland University Hospital
Start Date
2017-09-14
Trial ID
NCT03136133
Treatments Being Tested
The purpose of this study is to assess the safety profile of the Zaire Ebol...
Status
Completed
Location
Optimal Research
Start Date
2015-12-22
Trial ID
NCT02718469
Treatments Being Tested
Since its first outbreak occurred in 1976, Zaire Ebola virus have been asso...
Status
Completed
Location
Phase 1 vaccine clinical trial center of Jiangsu Provincial Center for Disease Control and Prevention
Start Date
2014-12
Trial ID
NCT02326194
This Phase 2 study aims to improve preparedness for future Ebola outbreaks ...
Status
Completed
Location
Hôpital Général de Référence de Boende
Start Date
2019-12-18
Trial ID
NCT04186000
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
This study seeks to evaluate the effectiveness of a remote training course ...
Status
Completed
Location
Stanford University
Start Date
2021-11-09
Trial ID
NCT05107479
Treatments Being Tested
The human monoclonal antibody (mAb), ansuvimab (mAb114), will be provided t...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05067166
Treatments Being Tested